Ocugen Inc
OCGN1.330USD
0.0000.00%
Fechamento 02/06, 16:00（ET）Cotações atrasadas em 15 min
415.39MValor de mercado
PerdaP/L TTM
Mais detalhes de Ocugen Inc Empresa
Ocugen, Inc. is a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines that improve health and offer hope for patients across the globe. Its technology pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, and Inhaled Mucosal Vaccine Platform. It is developing its modifier gene therapy platform, inclusive of OCU400, OCU410, and OCU410ST, for the treatment of multiple inherited retinal diseases, including retinitis pigmentosa, Leber congenital amaurosis, Stargardt disease and multifactorial diseases, such as dry age-related macular degeneration (dAMD) and geographic atrophy. It is developing a next-generation, inhalation-based mucosal vaccine platform based on a novel ChAd vector, which includes OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine, and OCU520, a combination quadrivalent seasonal flu.
Informações de Ocugen Inc
Código da empresaOCGN
Nome da EmpresaOcugen Inc
Data de listagemDec 03, 2014
CEOMusunuri (Shankar)
Número de funcionários95
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 03
Endereço11 Great Valley Parkway
CidadeMALVERN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal19355
Telefone14843284701
Sitehttps://ocugen.com/
Código da empresaOCGN
Data de listagemDec 03, 2014
CEOMusunuri (Shankar)
Executivos da empresa Ocugen Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Junge Zhang, Ph.D.
Mr. Junge Zhang, Ph.D.
Independent Director
Independent Director
1.17M
+117.00%
Dr. Arun Upadhyay, Ph.D.
Dr. Arun Upadhyay, Ph.D.
Chief Scientific Officer, Head of Research and Development
Chief Scientific Officer, Head of Research and Development
214.50K
+153362.00%
Mr. Ramesh Ramachandran, CPA
Mr. Ramesh Ramachandran, CPA
Chief Accounting Officer
Chief Accounting Officer
209.10K
+207300.00%
Dr. Shankar Musunuri, Ph.D.
Dr. Shankar Musunuri, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Uday B. Kompella, Ph.D.
Dr. Uday B. Kompella, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kirsten Castillo
Ms. Kirsten Castillo
Independent Director
Independent Director
--
--
Ms. Tiffany Hamilton
Ms. Tiffany Hamilton
Head of Communications
Head of Communications
--
--
Dr. Huma Qamar, M.D.
Dr. Huma Qamar, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Junge Zhang, Ph.D.
Mr. Junge Zhang, Ph.D.
Independent Director
Independent Director
1.17M
+117.00%
Dr. Arun Upadhyay, Ph.D.
Dr. Arun Upadhyay, Ph.D.
Chief Scientific Officer, Head of Research and Development
Chief Scientific Officer, Head of Research and Development
214.50K
+153362.00%
Mr. Ramesh Ramachandran, CPA
Mr. Ramesh Ramachandran, CPA
Chief Accounting Officer
Chief Accounting Officer
209.10K
+207300.00%
Dr. Shankar Musunuri, Ph.D.
Dr. Shankar Musunuri, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Dr. Uday B. Kompella, Ph.D.
Dr. Uday B. Kompella, Ph.D.
Independent Director
Independent Director
--
--
Ms. Kirsten Castillo
Ms. Kirsten Castillo
Independent Director
Independent Director
--
--
Detalhamento da receita
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2021
FY2020
Os dados relevantes ainda não foram divulgados pela empresa.
Por RegiãoUSD
Nome
Receita
Proporção
United States
1.75M
0.00%
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.
Distribuição de ações
Atualizado em: dom, 18 de jan
Atualizado em: dom, 18 de jan
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Janus Henderson Investors
6.10%
The Vanguard Group, Inc.
5.02%
UBS Financial Services, Inc.
1.43%
Musunuri (Shankar Ph.D)
1.36%
Millennium Management LLC
1.27%
Outro
84.82%
Investidores
Investidores
Proporção
Janus Henderson Investors
6.10%
The Vanguard Group, Inc.
5.02%
UBS Financial Services, Inc.
1.43%
Musunuri (Shankar Ph.D)
1.36%
Millennium Management LLC
1.27%
Outro
84.82%
Tipos de investidores
Investidores
Proporção
Investment Advisor
9.45%
Investment Advisor/Hedge Fund
8.28%
Hedge Fund
3.73%
Individual Investor
2.09%
Research Firm
0.47%
Corporation
0.35%
Venture Capital
0.14%
Bank and Trust
0.05%
Outro
75.44%
Participação acionária institucional
Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
260
72.72M
22.18%
+8.84M
2025Q3
255
51.36M
16.44%
-32.04M
2025Q2
268
78.45M
26.84%
-13.23M
2025Q1
278
81.07M
27.89%
-11.63M
2024Q4
292
76.62M
26.34%
-21.25M
2024Q3
306
84.66M
29.43%
-6.14M
2024Q2
300
72.04M
27.84%
+19.28M
2024Q1
302
36.88M
14.47%
-15.26M
2023Q4
300
30.54M
12.06%
-31.79M
2023Q3
314
37.28M
14.69%
-34.75M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Janus Henderson Investors
20.00M
6.4%
+19.70M
+6514.39%
Nov 28, 2025
The Vanguard Group, Inc.
15.22M
4.87%
+450.90K
+3.05%
Sep 30, 2025
UBS Financial Services, Inc.
841.04K
0.27%
+438.31K
+108.83%
Sep 30, 2025
Musunuri (Shankar Ph.D)
1.34M
0.46%
+607.32K
+82.50%
Apr 14, 2025
Millennium Management LLC
4.16M
1.33%
-896.78K
-17.73%
Sep 30, 2025
GMT Capital Corp.
4.15M
1.33%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.83M
1.23%
-1.36M
-26.19%
Sep 30, 2025
Geode Capital Management, L.L.C.
3.68M
1.18%
+189.39K
+5.43%
Sep 30, 2025
Citadel Advisors LLC
1.57M
0.5%
+966.20K
+160.49%
Sep 30, 2025
State Street Investment Management (US)
1.36M
0.43%
+16.46K
+1.23%
Sep 30, 2025
Ver Mais
ETFs Relacionados
Atualizado em: ter, 2 de dez
Atualizado em: ter, 2 de dez
Nome
Proporção
Invesco NASDAQ Future Gen 200 ETF
0.82%
Pacer WealthShield ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
Ver Mais
Invesco NASDAQ Future Gen 200 ETF
Proporção0.82%
Pacer WealthShield ETF
Proporção0%
iShares Russell 2000 ETF
Proporção0%
iShares Micro-Cap ETF
Proporção0%
ProShares UltraPro Russell2000
Proporção0%
ProShares Hedge Replication ETF
Proporção0%
iShares Core S&P Total U.S. Stock Market ETF
Proporção0%
iShares Russell 2000 Growth ETF
Proporção0%
Global X Russell 2000 ETF
Proporção0%
Proshares Ultra Russell 2000
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
